1. Home
  2. CSWC vs MDXG Comparison

CSWC vs MDXG Comparison

Compare CSWC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSWC
  • MDXG
  • Stock Information
  • Founded
  • CSWC 1961
  • MDXG 2006
  • Country
  • CSWC United States
  • MDXG United States
  • Employees
  • CSWC N/A
  • MDXG N/A
  • Industry
  • CSWC Textiles
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSWC Consumer Discretionary
  • MDXG Health Care
  • Exchange
  • CSWC Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • CSWC 1.3B
  • MDXG 1.1B
  • IPO Year
  • CSWC N/A
  • MDXG N/A
  • Fundamental
  • Price
  • CSWC $22.59
  • MDXG $6.94
  • Analyst Decision
  • CSWC Buy
  • MDXG Buy
  • Analyst Count
  • CSWC 5
  • MDXG 1
  • Target Price
  • CSWC $23.70
  • MDXG $12.00
  • AVG Volume (30 Days)
  • CSWC 528.6K
  • MDXG 439.7K
  • Earning Date
  • CSWC 10-27-2025
  • MDXG 10-29-2025
  • Dividend Yield
  • CSWC 11.23%
  • MDXG N/A
  • EPS Growth
  • CSWC N/A
  • MDXG N/A
  • EPS
  • CSWC 1.64
  • MDXG 0.21
  • Revenue
  • CSWC $209,032,000.00
  • MDXG $363,774,000.00
  • Revenue This Year
  • CSWC $14.15
  • MDXG $12.68
  • Revenue Next Year
  • CSWC $10.11
  • MDXG $8.18
  • P/E Ratio
  • CSWC $13.85
  • MDXG $32.78
  • Revenue Growth
  • CSWC 10.52
  • MDXG 6.85
  • 52 Week Low
  • CSWC $17.46
  • MDXG $5.47
  • 52 Week High
  • CSWC $25.90
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • CSWC 47.12
  • MDXG 46.17
  • Support Level
  • CSWC $22.35
  • MDXG $6.89
  • Resistance Level
  • CSWC $23.00
  • MDXG $7.14
  • Average True Range (ATR)
  • CSWC 0.29
  • MDXG 0.18
  • MACD
  • CSWC -0.03
  • MDXG -0.04
  • Stochastic Oscillator
  • CSWC 34.29
  • MDXG 29.55

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: